Back to search

Article

Downregulated the expression of DNMT3B by suppressing PI3K/Akt signaling pathway and enhances the chemosensitivity of glioblastoma to temozolomide.

2023-10-03

Abstract excerpt

<title>Abstract</title> <p>Purpose Glioblastoma is the most common malignant brain tumors and has the poorest prognosis. And a poor prognosis is attributed to chemoresistance to temozolomide (TMZ), the first-line drug for treating glioblastoma. This study aimed to investigate how to enhance the chemosensitivity of glioblastoma to temozolomide. Methods Human glioblastoma cell line U251 was used to established te...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
beb9e15a-b2e6-519f-86e3-659af8c307b4
DOI
10.21203/rs.3.rs-3358904/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Downregulated the expression of DNMT3B by suppressing PI3K/Akt signaling pathway and enhances the chemosensitivity of glioblastoma to temozolomide.DOI 10.21203/rs.3.rs-3358904/v1
Select a neighboring publication to make it the new centre.